THE PEBBLE INSTITUTE CIC

Active United Kingdom

Research and experimental development on biotechnology

3 employees website.com
Research and experimental development on biotechnologyOther professional, scientific and technical activities n.e.c.
T

THE PEBBLE INSTITUTE CIC

Research and experimental development on biotechnology

Founded 7 Apr 2020 Active United Kingdom 3 employees website.com
Research and experimental development on biotechnologyOther professional, scientific and technical activities n.e.c.

Previous Company Names

THE EX-VIVO RESEARCH CENTRE CIC 7 Apr 2020 — 3 May 2024
Accounts Submitted 26 Jan 2026 Next due 31 Jan 2027 8 months remaining
Confirmation Submitted 19 May 2026 Next due 12 May 2027 11 months remaining
Net assets £10K £23K 2024 year on year
Total assets £15K £32K 2024 year on year
Total Liabilities £5K £9K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Full company profile for THE PEBBLE INSTITUTE CIC (12550552), an active company based in United Kingdom. Incorporated 7 Apr 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 May → 30 Apr 2024
Type total-exemption-full
Next accounts 30 Apr 2026
Due by 31 Jan 2027 8 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£1.64k

Decreased by £11.88k (-88%)

Net Assets

£10.21k

Decreased by £22.94k (-69%)

Total Liabilities

£4.94k

Decreased by £8.88k (-64%)

Turnover

N/A

Employees

3

Increased by 1 (+50%)

Debt Ratio

33%

Increased by 4 (+14%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
30 Apr Year End
2023
30 Apr Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
Claydon, Mark RoyDirectorBritishEngland5212 Feb 2024Active
Entwistle, Timothy Rys, DrDirectorBritishUnited Kingdom517 Apr 2020Active
Stone, John Philip, DrDirectorBritishUnited Kingdom387 Apr 2020Active

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
19 May 2026Confirmation StatementConfirmation statement made on 28 Apr 2026 with no updates
26 Jan 2026AccountsAnnual accounts made up to 30 Apr 2025
15 May 2025OfficersTermination of Sandra Maria Johnson-Wallis as director on 9 May 2025
28 Apr 2025Confirmation StatementConfirmation statement made on 28 Apr 2025 with no updates
7 Apr 2025Confirmation StatementConfirmation statement made on 6 Apr 2025 with no updates
19 May 2026 Confirmation Statement

Confirmation statement made on 28 Apr 2026 with no updates

26 Jan 2026 Accounts

Annual accounts made up to 30 Apr 2025

15 May 2025 Officers

Termination of Sandra Maria Johnson-Wallis as director on 9 May 2025

28 Apr 2025 Confirmation Statement

Confirmation statement made on 28 Apr 2025 with no updates

7 Apr 2025 Confirmation Statement

Confirmation statement made on 6 Apr 2025 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 28 Apr 2026 with no updates

2 weeks ago on 19 May 2026

Annual accounts made up to 30 Apr 2025

4 months ago on 26 Jan 2026

Termination of Sandra Maria Johnson-Wallis as director on 9 May 2025

1 years ago on 15 May 2025

Confirmation statement made on 28 Apr 2025 with no updates

1 years ago on 28 Apr 2025

Confirmation statement made on 6 Apr 2025 with no updates

1 years ago on 7 Apr 2025